CHLORPROMAZINE vs haloperidol: Leaving the study early
- Population
- patients with psychosis‐induced aggression or agitation
- Intervention
- CHLORPROMAZINE
- Comparison
- haloperidol
- Outcome
- Leaving the study early
It is very uncertain whether CHLORPROMAZINE changes leaving the study early compared with HALOPERIDOL (very low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
CHLORPROMAZINE vs HALOPERIDOL Leaving the study early · patients with psychosis induced aggression or agitation It is very uncertain whether CHLORPROMAZINE changes leaving the study early compared with HALOPERIDOL (very low certainty). Chlorpromazine for psychosis induced aggression or agitation (2010) · Cochrane Headline outcomes only | RR 2 [0.2, 19.78] | 1 study · 30 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Chlorpromazine for psychosis induced aggression or agitation 2010 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- CHLORPROMAZINE vs Clotiapine · patients with schizophrenia · 1 review
- CHLORPROMAZINE vs piperacetazine · patients with schizophrenia · 1 review
- CHLORPROMAZINE vs placebo · patients with schizophrenia · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.